Smoking Trends and Lung Cancer Mortality: The Good, the Bad, and the Ugly
Authors: Gerard A. Silvestri, Matthew J. Carpenter
Journal: Annals of Internal Medicine (2018)

Editorials20 November 2018Smoking Trends and Lung Cancer Mortality: The Good, the Bad, and the UglyGerard A. Silvestri, MD, MS and Matthew J. Carpenter, PhDGerard A. Silvestri, MD, MSHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina (G.A.S., M.J.C.)Search for more papers by this author and Matthew J. Carpenter, PhDHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina (G.A.S., M.J.C.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-2775 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The lung cancer literature is replete with opening comments to the effect that “lung cancer is the leading cause of cancer death in both men and women and accounts for more deaths than breast, colon, and prostate cancer combined.” Many of these articles note that “more women will die of lung cancer than breast, cervical, and ovarian cancer combined.” Although neither of these facts is disputed, these articles could and perhaps should start with a sentence that directly links lung cancer deaths to cigarette smoking, the most preventable cause of cancer death for both men and women in the United ...References1. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Accessed at www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm on 4 October 2018. Google Scholar2. Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67:53-9. [PMID: 29346338] doi:10.15585/mmwr.mm6702a1 CrossrefMedlineGoogle Scholar3. Jeon J, Holford TR, Levy DT, Feuer EJ, Cao P, Tam J, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065. A comparative modeling approach. Ann Intern Med. 2018;169:684-93. doi:10.7326/M18-1250 LinkGoogle Scholar4. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409. [PMID: 21714641] doi:10.1056/NEJMoa1102873 CrossrefMedlineGoogle Scholar5. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-8. [PMID: 24378917]. doi:10.7326/M13-2771 LinkGoogle Scholar6. Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, et al. The association between smoking abstinence and mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016;193:534-41. [PMID: 26502000] doi:10.1164/rccm.201507-1420OC CrossrefMedlineGoogle Scholar7. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncol. 2017;3:1278-81. [PMID: 28152136] doi:10.1001/jamaoncol.2016.6416 CrossrefMedlineGoogle Scholar8. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007;62:126-30. [PMID: 17101739] CrossrefMedlineGoogle Scholar9. Centers for Disease Control and Prevention. State Tobacco Activities Tracking and Evaluation (STATE) System. Map of Current Cigarette Use Among Adults. Updated 19 September 2017. Accessed at www.cdc.gov/statesystem/cigaretteuseadult.html on 4 October 2018. Google Scholar10. National Cancer Institute. A Socioecological Approach to Addressing Tobacco-Related Health Disparities. National Cancer Institute Tobacco Control Monograph 22. NIH publication no. 17-CA-8035A. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2017. Google Scholar Author, Article, and Disclosure InformationAffiliations: Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina (G.A.S., M.J.C.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-2775.Corresponding Author: Gerard A. Silvestri, MD, MS, Hillenbrand Professor of Thoracic Oncology, Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425; e-mail, [email protected]edu.Current Author Addresses: Dr. Silvestri: Hillenbrand Professor of Thoracic Oncology, Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425.Dr. Carpenter: Medical University of South Carolina, 68 President Street, BEB 103T Bioengineering Building, Charleston, SC 29425.This article was published at Annals.org on 9 October 2018. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSmoking and Lung Cancer Mortality in the United States From 2015 to 2065 Jihyoun Jeon , Theodore R. Holford , David T. Levy , Eric J. Feuer , Pianpian Cao , Jamie Tam , Lauren Clarke , John Clarke , Chung Yin Kong , and Rafael Meza Metrics Cited byDevelopment and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung AdenocarcinomaLung Cancer 2020 20 November 2018Volume 169, Issue 10Page: 721-722KeywordsCancer screeningDisclosureForecastingLung and intrathoracic tumorsLung cancer screeningMortalityPopulation statisticsSmoking cessationThoraxTobacco control ePublished: 9 October 2018 Issue Published: 20 November 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...